Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel
Journal cover image

Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis.

Publication ,  Journal Article
Abedrabbo, N; Lerner, E; Lam, E; Kadi, D; Dawit, H; van der Pol, C; Salameh, J-P; Naringrekar, H; Adamo, R; Alabousi, M; Levis, B; Tang, A ...
Published in: Abdom Radiol (NY)
April 2025

BACKGROUND: The Liver Imaging Reporting and Data System (LI-RADS) does not consider factors extrinsic to the observation of interest, such as concurrent LR-5 observations. PURPOSE: To evaluate whether the presence of a concurrent LR-5 observation is associated with a difference in the probability that LR-3 or LR-4 observations represent hepatocellular carcinoma (HCC) through an individual participant data (IPD) meta-analysis. METHODS: Multiple databases were searched from 1/2014 to 2/2023 for studies evaluating the diagnostic accuracy of CT/MRI for HCC using LI-RADS v2014/2017/2018. The search strategy, study selection, and data collection process can be found at https://osf.io/rpg8x . Using a generalized linear mixed model (GLMM), IPD were pooled across studies and modeled simultaneously with a one-stage meta-analysis approach to estimate positive predictive value (PPV) of LR-3 and LR-4 observations without and with concurrent LR-5 for the diagnosis of HCC. Risk of bias was assessed using a composite reference standard and Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). RESULTS: Twenty-nine studies comprising 2591 observations in 1456 patients (mean age 59 years, 1083 [74%] male) were included. 587/1960 (29.9%) LR-3 observations in 1009 patients had concurrent LR-5. The PPV for LR-3 observations with concurrent LR-5 was not significantly different from the PPV without LR-5 (45.4% vs 37.1%, p = 0.63). 264/631 (41.8%) LR-4 observations in 447 patients had concurrent LR-5. The PPV for LR-4 observations with concurrent LR-5 was not significantly different from LR-4 observations without concurrent LR-5 (88.6% vs 69.5%, p = 0.08). A sensitivity analysis for low-risk of bias studies (n = 9) did not differ from the primary analysis. CONCLUSION: The presence of concurrent LR-5 was not significantly associated with differences in PPV for HCC in LR-3 or LR-4 observations, supporting the current LI-RADS paradigm, wherein the presence of synchronous LR-5 may not alter the categorization of LR-3 and LR-4 observations.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Abdom Radiol (NY)

DOI

EISSN

2366-0058

Publication Date

April 2025

Volume

50

Issue

4

Start / End Page

1533 / 1546

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Predictive Value of Tests
  • Magnetic Resonance Imaging
  • Liver Neoplasms
  • Humans
  • Carcinoma, Hepatocellular
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Abedrabbo, N., Lerner, E., Lam, E., Kadi, D., Dawit, H., van der Pol, C., … Bashir, M. (2025). Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis. Abdom Radiol (NY), 50(4), 1533–1546. https://doi.org/10.1007/s00261-024-04580-6
Abedrabbo, Nicole, Emily Lerner, Eric Lam, Diana Kadi, Haben Dawit, Christian van der Pol, Jean-Paul Salameh, et al. “Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis.Abdom Radiol (NY) 50, no. 4 (April 2025): 1533–46. https://doi.org/10.1007/s00261-024-04580-6.
Abedrabbo N, Lerner E, Lam E, Kadi D, Dawit H, van der Pol C, et al. Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis. Abdom Radiol (NY). 2025 Apr;50(4):1533–46.
Abedrabbo, Nicole, et al. “Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis.Abdom Radiol (NY), vol. 50, no. 4, Apr. 2025, pp. 1533–46. Pubmed, doi:10.1007/s00261-024-04580-6.
Abedrabbo N, Lerner E, Lam E, Kadi D, Dawit H, van der Pol C, Salameh J-P, Naringrekar H, Adamo R, Alabousi M, Levis B, Tang A, Alhasan A, Arvind A, Singal A, Allen B, Bartnik K, Podgórska J, Furlan A, Cannella R, Dioguardi Burgio M, Cerny M, Choi SH, Clarke C, Jing X, Kierans A, Ronot M, Rosiak G, Jiang H, Song JS, Reiner CC, Joo I, Kwon H, Wang W, Rao S-X, Diaz Telli F, Piñero F, Seo N, Kang H-J, Wang J, Min JH, Costa A, McInnes M, Bashir M. Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis. Abdom Radiol (NY). 2025 Apr;50(4):1533–1546.
Journal cover image

Published In

Abdom Radiol (NY)

DOI

EISSN

2366-0058

Publication Date

April 2025

Volume

50

Issue

4

Start / End Page

1533 / 1546

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Predictive Value of Tests
  • Magnetic Resonance Imaging
  • Liver Neoplasms
  • Humans
  • Carcinoma, Hepatocellular